High-fidelity, sensitive, and powerful technologies revolutionize analysis of the most challenging genomic samples and let you imagine more from less.
NuGEN’s proprietary SPIA® technology is an elegant method for linear isothermal amplification of nucleic acids. This simple, high-fidelity approach to amplification enables global genomic analysis of limited and/or compromised biological samples, overcoming the challenges of sample quality and quantity with a high degree of sensitivity and accuracy.
Complex microarray platforms and various dissection technologies have evolved to enable analysis of highly homogenous biological samples. As a result, researchers have gained new opportunities to work with samples comprised of low numbers of cells such as laser captured microdissections, fine-needle aspirates, sorted cells, circulating tumor cells, embryonic structures, biopsies and Formalin-Fixed Paraffin-Embedded (FFPE) samples. Such sources often yield extremely small amounts of compromised RNA or DNA, adding to the difficulty in investigating these biological samples.
These challenges are met with NuGEN’s innovative technologies, which are at the core of a robust, sensitive, and easy to automate family of products and solutions that enable today’s discovery and clinical research projects.
SPIA® |
Ribo-SPIA® |
See 3-Prime Ribo-SPIA® in Action
Watch a one-minute animation of our unique 3-prime amplification technology.
See WT Ribo-SPIA® in Action
Watch a one-minute animation of our unique whole transcriptome amplification technology.